Press Release

SOLE (Study of Letrozole Extension):A phase III randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer

Primary results of LORELEI study presentedat ESMO 2017 Congress

PANACEA study suggests immunotherapy may help to overcome trastuzumab-resistant breast cancer

Ovarian Suppression Reduces Recurrence for Young Breast Cancer Patients

1 out of 3 men with breast cancer does not receive adequate treatment

Belgium has the highest incidence of breast cancer in the world!

Progress in the fight against metastatic breas cancer

The BIG Radio Tuning clinical study

Breast cancer prevention – significant progress: 49% reduction in breast cancer occurrence with anastrozole (long-term follow up results of the IBIS II Prevention trial)

Update on PALLAS, an International Academic Breast Cancer Study Evaluating Adjuvant Palbociclib